Search research articles
Contact Us
Filters
Showing results (501-510 of 532) with videos related to
Page
of 54
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2013
Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer
Ke-Da Yu, Rui Zhu, Ming Zhan, et al.
Plos One
|
April 17, 2020
Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets
Olga Y Korolkova, Sarrah E Widatalla, Diva S Whalen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 19, 2005
Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation
C Holmes, C Ballard, D Lehmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2013
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition
Katherine E Hutchinson, Doron Lipson, Philip J Stephens, et al.
Breast Cancer Research : BCR
|
August 9, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Brian D Lehmann, Joshua A Bauer, Johanna M Schafer, et al.
Oncotarget
|
May 15, 2015
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
Andrew J Wilson, Oluwole Fadare, Alicia Beeghly-Fadiel, et al.
Nature Communications
|
November 2, 2021
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
Brian D Lehmann, Antonio Colaprico, Tiago C Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer
Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri, et al.
Plos Computational Biology
|
August 6, 2016
Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells
Ruth Merkle, Bernhard Steiert, Florian Salopiata, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 6, 2023
Loss of p73 Expression Contributes to Chronic Obstructive Pulmonary Disease
Bradley W Richmond, Clayton B Marshall, Jessica B Blackburn, et al.
Page
of 54
Search research articles
Search
Showing results (501-510 of 532) with videos related to
Sort By:
Page
of 54
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 4, 2013
Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer
Ke-Da Yu, Rui Zhu, Ming Zhan, et al.
Plos One
|
April 17, 2020
Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets
Olga Y Korolkova, Sarrah E Widatalla, Diva S Whalen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
April 19, 2005
Rate of progression of cognitive decline in Alzheimer's disease: effect of butyrylcholinesterase K gene variation
C Holmes, C Ballard, D Lehmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 19, 2013
BRAF fusions define a distinct molecular subset of melanomas with potential sensitivity to MEK inhibition
Katherine E Hutchinson, Doron Lipson, Philip J Stephens, et al.
Breast Cancer Research : BCR
|
August 9, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Brian D Lehmann, Joshua A Bauer, Johanna M Schafer, et al.
Oncotarget
|
May 15, 2015
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
Andrew J Wilson, Oluwole Fadare, Alicia Beeghly-Fadiel, et al.
Nature Communications
|
November 2, 2021
Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes
Brian D Lehmann, Antonio Colaprico, Tiago C Silva, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2025
Phase Ib Trial of Fulvestrant, Palbociclib, and Erdafitinib, a pan-FGFR Tyrosine Kinase Inhibitor, in HR+/HER2- Metastatic Breast Cancer
Paula I Gonzalez-Ericsson, Nisha Unni, Komal Jhaveri, et al.
Plos Computational Biology
|
August 6, 2016
Identification of Cell Type-Specific Differences in Erythropoietin Receptor Signaling in Primary Erythroid and Lung Cancer Cells
Ruth Merkle, Bernhard Steiert, Florian Salopiata, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 6, 2023
Loss of p73 Expression Contributes to Chronic Obstructive Pulmonary Disease
Bradley W Richmond, Clayton B Marshall, Jessica B Blackburn, et al.
Page
of 54